 DUBLIN, Sept. 13, 2021 PRNewswire -- Medtronic plc NYSE:MDT, the global leader in medical technology, today announced it has won three additional important victories in a dispute over its intellectual property IP for its sacral neuromodulation device family, the InterStimTM systems. 